Adherence to a guideline for coumarins in pregnancy
- 34 Downloads
- 2 Citations
Abstract
Objective: To asses the adherence in daily clinical practice to a guideline for anticoagulation during pregnancy.
Methods: The Dutch anticoagulation clinics developed a pregnancy guideline for anticoagulant therapy in order to avoid foetal exposure to coumarins between the 6th and 9th week of gestation. Anticoagulation was studied in 282 prospectively-registered pregnant women, who were treated by 26 different anticoagulation clinics.
Results: The guideline was adhered to in 93% of treated women. Conforming to the guideline, the majority of patients commenced anticoagulation with heparin in the first trimester (n = 81) or started treatment from the second trimester onwards (n = 168). At the time of conception, 31 anticoagulated women were on coumarin treatment. In 13 of these patients (42%), coumarins were withdrawn before the 6th gestational week. In two pregnant women coumarin therapy started unintentionally during the first trimester of gestation.
Conclusion: The present study shows that the guideline under study is useful in daily clinical practice. A careful instruction of women of child-bearing age who need medication remains important.
Preview
Unable to display preview. Download preview PDF.
References
- 1.Van Driel D, Wesseling J, Sauer PJJ, Touwen BCL, Van der Veer E, Heymans HSA. Teratogen update: fetal effects after in utero ex-posure to coumarins. Teratology 2002; 66: 127–40.CrossRefPubMedGoogle Scholar
- 2.Nelson-Piercy C. Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis. Baillière Clin Obstet Gyne-col 1997; 11: 489–509.Google Scholar
- 3.Hanania G, Thomas D, Michel P L, G arbarz E, Age C, Millaire A et al. Pregnancy and prosthetic heart valves: a French coopera-tive retrospective study of 155 cases. Eur Heart J 1994; 15: 1651–8.PubMedGoogle Scholar
- 4.Stibbe J, van Dijk-Wierda CA. Antistollingsbehandeling in de zwangerschap.[Anticoagulant therapy in pregnancy.] Tromni-bus 1980; 8: 1–6.Google Scholar
- 5.Gohlke-Barwolf C, Acar J, Oakley C, Butchart E, Burckhart D, Bodnar E et al.Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Car-diology. Eur Heart J 1995; 16: 1320–30.Google Scholar
- 6.Wesseling J, Van Driel D, Heymans HSA, Rosendaal FR, Geven-Boere LM, Smrkovsky M et al. Coumarins during pregnancy: long-term effects on growth and development of school-age children. Thromb Haemost 2001; 85: 609–13.PubMedGoogle Scholar
- 7.Statistical Package for the Social Sciences version 7.5 for Windows. Chicago, Illinois: SPSS 1997.Google Scholar
- 8.Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994; 71: 196–201.PubMedGoogle Scholar
- 9.Robin F, Lecuru F, Desfeux P, Boucay V, Taurelle R. Anticoagulant therapy in pregnancy. Eur J Obstet Gyn Reprod Biol 1999; 83: 171–7CrossRefGoogle Scholar
- 10.Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PC et al. Why don't physicians follow clinical practice guide-lines? A framework for improvement. JAMA 1999; 282: 1458–65.PubMedGoogle Scholar